Central Drug Labs set up at Pune, Hyderabad for COVID vaccine testing
Advertisement
New Delhi: In the wake of the COVID-19 pandemic, and considering the enhanced production of COVID vaccines, the Government of India has set up two laboratories to facilitate expedited testing/pre-release certification of the vaccines, informed the Union Ministry of Science and Technology on Sunday.
According to the ministry, the Government of India has set up two vaccine testing facilities including one at Autonomous Research Institutes National Centre for Cell Science (NCCS), Pune, and another at National Institute of Animal Biotechnology (NIAB) Hyderabad as Central Drug Laboratory (CDL), for batch testing and quality control of vaccines.
Currently, the nation has a Central Drugs Laboratory (CDL) at Kasauli, which is the National Control Laboratory for testing and pre-release certification of Immunobiologicals (vaccines and antisera) meant for human use in India, it said.
Accordingly, with funding support provided by the PM-CARES Funds trust, two new vaccine testing facilities have been set up as Central Drug laboratories at DBT- NCCS, and DBT-NIAB, said the ministry.
It stated that since the COVID-19 pandemic, the Department of Biotechnology has been at the forefront contributing to various COVID-19 related activities including Vaccine Development, Diagnostics and testing, bio-banking and genomic surveillance, in addition to fundamental research and also building a strong ecosystem for translational research.
DBT-NCCS and DBT-NIAB have been the pillars for many aspects of infectious disease-related work in India and have contributed to the advancement of cutting-edge research output in frontier areas of Biotechnology relevant to human health and disease.
The ministry stated that the facility at NCCS, Pune, has now been notified as Central Drugs Laboratory for testing and lot release of COVID-19 vaccines vide. Gazette notification issued by the Ministry of Health and Family Welfare on June 28, 2021, it said.
The facility at NIAB, Hyderabad is likely to receive necessary notification shortly, it added.
As per the ministry, with generous support from PM CARES Fund trust in a very short span of time, both the institutions through relentless efforts have set up state-of-the-art modern facilities for this purpose.
It stated that the facilities are expected to test approx 60 batches of vaccines per month. The facilities are geared up to test existing COVID-19 vaccines and other newer COVID-19 vaccines as per the demand of the nation, it said.
This will not only expedite the vaccine manufacture and supply but also be logistically convenient considering that both Pune and Hyderabad are the two Vaccine manufacturing hubs, stated the ministry.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.